CN118166045A - Preparation method and application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride - Google Patents
Preparation method and application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride Download PDFInfo
- Publication number
- CN118166045A CN118166045A CN202410345594.3A CN202410345594A CN118166045A CN 118166045 A CN118166045 A CN 118166045A CN 202410345594 A CN202410345594 A CN 202410345594A CN 118166045 A CN118166045 A CN 118166045A
- Authority
- CN
- China
- Prior art keywords
- reaction
- triglyceride
- acid
- opo
- opl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 89
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 27
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 27
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 27
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims abstract description 27
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000005642 Oleic acid Substances 0.000 claims abstract description 27
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 27
- 235000020778 linoleic acid Nutrition 0.000 claims abstract description 27
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 27
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 27
- 150000002632 lipids Chemical class 0.000 claims abstract description 26
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 24
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000019482 Palm oil Nutrition 0.000 claims abstract description 18
- 239000002540 palm oil Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 238000000199 molecular distillation Methods 0.000 claims abstract description 17
- 239000003921 oil Substances 0.000 claims abstract description 16
- 235000019198 oils Nutrition 0.000 claims abstract description 16
- 108090001060 Lipase Proteins 0.000 claims abstract description 13
- 102000004882 Lipase Human genes 0.000 claims abstract description 13
- 239000004367 Lipase Substances 0.000 claims abstract description 13
- 235000019421 lipase Nutrition 0.000 claims abstract description 13
- 210000004185 liver Anatomy 0.000 claims abstract description 12
- 235000021588 free fatty acids Nutrition 0.000 claims abstract description 10
- 108010048733 Lipozyme Proteins 0.000 claims description 24
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 22
- 239000000758 substrate Substances 0.000 claims description 22
- 235000013350 formula milk Nutrition 0.000 claims description 17
- 230000035484 reaction time Effects 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 claims description 15
- 235000021314 Palmitic acid Nutrition 0.000 claims description 11
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 11
- 238000003760 magnetic stirring Methods 0.000 claims description 10
- 235000013336 milk Nutrition 0.000 claims description 10
- 239000008267 milk Substances 0.000 claims description 10
- 210000004080 milk Anatomy 0.000 claims description 10
- 229960001947 tripalmitin Drugs 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 3
- 230000004584 weight gain Effects 0.000 claims description 3
- 235000019786 weight gain Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 2
- 241000699670 Mus sp. Species 0.000 abstract description 26
- 241000699666 Mus <mouse, genus> Species 0.000 abstract description 7
- 230000007062 hydrolysis Effects 0.000 abstract description 7
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 235000005911 diet Nutrition 0.000 abstract description 3
- 230000000378 dietary effect Effects 0.000 abstract description 3
- 210000002966 serum Anatomy 0.000 abstract description 2
- 235000019197 fats Nutrition 0.000 description 16
- 235000020256 human milk Nutrition 0.000 description 16
- 210000004251 human milk Anatomy 0.000 description 16
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 230000037396 body weight Effects 0.000 description 11
- 150000003626 triacylglycerols Chemical group 0.000 description 10
- 235000012000 cholesterol Nutrition 0.000 description 9
- 235000012424 soybean oil Nutrition 0.000 description 8
- 239000003549 soybean oil Substances 0.000 description 8
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical group NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 7
- 125000003473 lipid group Chemical group 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000037356 lipid metabolism Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 238000011725 BALB/c mouse Methods 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 235000019733 Fish meal Nutrition 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000004467 fishmeal Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241000223258 Thermomyces lanuginosus Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 235000013341 fat substitute Nutrition 0.000 description 1
- 239000003778 fat substitute Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Nutrition Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
Abstract
本发明提供了一种1,3‑二不饱和脂肪酸‑2‑棕榈酸甘油三酯的制备方法及应用,属于功能性结构脂质制备技术领域,本发明以富含三棕榈酸甘油三酯(PPP)的精炼棕榈油为原料,经水解特异性固定化脂肪酶催化,反应前半程只加入有机油酸,后半程加入有机亚油酸,待反应结束后经分子蒸馏去除游离脂肪酸,以最终获得富含OPO、OPL和LPL的有机油脂组合物,并将上述功能脂质喂养小鼠探究其对小鼠体重和血清生化指标。结果显示,所制备的功能性结构脂质有效的降低了小鼠的体重、肝脏甘油三酯和总胆固醇水平,为功能脂质的膳食应用提供理论依据。The present invention provides a preparation method and application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride, which belongs to the technical field of functional structural lipid preparation. The present invention uses refined palm oil rich in tripalmitoyl triglyceride (PPP) as raw material, catalyzed by hydrolysis-specific immobilized lipase, only organic oleic acid is added in the first half of the reaction, and organic linoleic acid is added in the second half. After the reaction is completed, free fatty acids are removed by molecular distillation to finally obtain an organic oil composition rich in OPO, OPL and LPL, and the above-mentioned functional lipids are fed to mice to explore their effects on mouse weight and serum biochemical indicators. The results show that the prepared functional structural lipids effectively reduce the weight, liver triglyceride and total cholesterol levels of mice, providing a theoretical basis for the dietary application of functional lipids.
Description
技术领域Technical Field
本发明涉及功能性结构脂质制备技术领域,公开了一种1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯的制备方法及其在小鼠脂质代谢中的应用。The invention relates to the technical field of functional structure lipid preparation, and discloses a preparation method of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride and application of the same in lipid metabolism of mice.
背景技术Background technique
母乳脂肪约占母乳重量的3~5%,是母乳的重要营养物质,其主要成分是由多种脂肪酸与甘油结合形成的甘油三酯(98~99%),它为婴儿提供所需的约50%能量,还为婴儿提供必需脂肪酸、功能性脂肪酸和脂溶性维生素等营养成分,对婴儿的大脑与神经系统发育具有重要作用。Breast milk fat accounts for about 3-5% of the weight of breast milk and is an important nutrient in breast milk. Its main component is triglycerides (98-99%) formed by the combination of multiple fatty acids and glycerol. It provides about 50% of the energy needed by infants, and also provides infants with essential fatty acids, functional fatty acids, fat-soluble vitamins and other nutrients, which play an important role in the development of the infant's brain and nervous system.
目前,婴儿配方奶粉均是以母乳组成为黄金标准来进行生产。就脂肪而言,脂肪在配方奶粉中含量约占25%左右,为配方奶粉中的重要组成部分。婴幼儿配方奶粉厂家主要是通过调节脂肪酸组成使配方奶粉中油脂与母乳一致,或者通过向配方奶粉中添加1,3-二油酸-2-棕榈酸甘油三酯(OPO)结构脂,从而模拟母乳脂肪的结构。但OPO结构脂仅为母乳脂肪中的一种甘油三酯,OPO是欧美国家母乳中含量最高的甘油三酯,而中国母乳中含量最高的是1-油酸-2-棕榈酸-3-亚油酸甘油三酯(OPL)。临床试验表明,喂食母乳和含猪油的奶粉的婴儿,比喂食配方奶粉的婴儿表现出更高的脂肪、钙的吸收和更低的粪便硬度,以往仅强调了OPO对婴幼儿的生理功能,实际上对婴幼儿脂肪吸收、粪便硬度有益的是一类1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯(UPU)的综合作用,包括OPL、LPL及其他微量UPU,因此仅研究OPO是不完整的。At present, infant formula milk powder is produced with breast milk composition as the gold standard. As far as fat is concerned, fat accounts for about 25% of formula milk powder, which is an important component of formula milk powder. Infant formula milk powder manufacturers mainly adjust the fatty acid composition to make the fat in formula milk powder consistent with breast milk, or by adding 1,3-dioleoyl-2-palmitoyl triglyceride (OPO) structural fat to formula milk powder to simulate the structure of breast milk fat. However, OPO structural fat is only one type of triglyceride in breast milk fat. OPO is the triglyceride with the highest content in breast milk in Europe and the United States, while the highest content in Chinese breast milk is 1-oleoyl-2-palmitoyl-3-linoleic acid triglyceride (OPL). Clinical trials have shown that infants fed with breast milk and lard-containing milk powder show higher fat and calcium absorption and lower stool hardness than infants fed with formula milk. In the past, only the physiological function of OPO on infants and young children was emphasized. In fact, what is beneficial to the fat absorption and stool hardness of infants and young children is the comprehensive effect of a class of 1,3-diunsaturated fatty acids-2-palmitoyl triglycerides (UPU), including OPL, LPL and other trace amounts of UPU. Therefore, it is incomplete to study only OPO.
棕榈酸是母乳脂肪中较为特殊的一种脂肪酸,国外称sn-2棕榈酸甘油三酯,其中又以UPU结构为主。UPU是人乳脂中典型的甘油三酯,不仅仅为婴幼儿提供能量和营养,且在消化过程中水解下来的游离油酸和亚油酸等不饱和脂肪酸与肠道中钙镁离子不易形成皂盐,增强脂肪和钙的吸收,不会引起婴儿便秘,并影响甘油三酯在婴儿体内的脂质代谢,从而维持其肠道通畅。典型的UPU包括OPL、OPO、1,3-二亚油酸-2-棕榈酸甘油三酯(LPL)、1-油酸-2-棕榈酸-3-亚麻酸甘油三酯(OPLn)、1-亚油酸-2-棕榈酸-3-亚麻酸甘油三酯(LPLn),及一些sn-2棕榈酸与sn-1,3长碳链多不饱和脂肪酸(如DHA等)组合的甘油三酯。因此,合成UPU结构甘油三酯添加于配方奶粉,可更好模拟母乳脂肪甘油三酯组成。Palmitic acid is a special fatty acid in breast milk fat, which is called sn-2 palmitic acid triglyceride abroad, and the UPU structure is the main one. UPU is a typical triglyceride in human milk fat. It not only provides energy and nutrition for infants and young children, but also the unsaturated fatty acids such as free oleic acid and linoleic acid hydrolyzed during digestion are not easy to form soap salts with calcium and magnesium ions in the intestine, which enhances the absorption of fat and calcium, does not cause constipation in infants, and affects the lipid metabolism of triglycerides in infants, thereby maintaining their intestinal patency. Typical UPUs include OPL, OPO, 1,3-dilinoleic acid-2-palmitic acid triglyceride (LPL), 1-oleic acid-2-palmitic acid-3-linolenic acid triglyceride (OPLn), 1-linoleic acid-2-palmitic acid-3-linolenic acid triglyceride (LPLn), and some triglycerides composed of sn-2 palmitic acid and sn-1,3 long-chain polyunsaturated fatty acids (such as DHA, etc.). Therefore, adding synthetic UPU structured triglycerides to formula milk can better simulate the triglyceride composition of breast milk fat.
目前关于UPU功能性结构脂质的报道,主要采用酶法酸解三棕榈酸甘油酯的方法,存在操作复杂,反应时间长,温度高,酰基迁移不可避免,产品纯度普遍不高等问题。因此,提供一种简单高效的制备方法,提高有机结构脂中OPO含量和Sn-2棕榈酸占比,降低婴儿肠道内皂钙的形成,减少婴儿便秘的几率,使婴幼儿奶粉中脂肪酸的结构与比例接近母乳,能够改善婴儿对脂肪的消化代谢,对推进婴幼儿配方奶粉母乳化进程具有重要的意义。At present, reports on UPU functional structural lipids mainly use the method of enzymatic acid hydrolysis of tripalmitin, which has the problems of complex operation, long reaction time, high temperature, inevitable acyl migration, and generally low product purity. Therefore, a simple and efficient preparation method is provided to increase the OPO content and the proportion of Sn-2 palmitic acid in organic structural lipids, reduce the formation of saponin in the infant intestine, reduce the chance of infant constipation, make the structure and proportion of fatty acids in infant formula close to breast milk, improve infant fat digestion and metabolism, and have important significance for promoting the breast milkization process of infant formula.
发明内容Summary of the invention
为了解决以上存在的问题,本发明提供了一种1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯的制备方法及小鼠脂质代谢的应用。通过高效专一的脂肪酶及固定化技术(来自疏绵状嗜热丝孢菌,默克公司),使用结构脂的空间结构调控及占比调控的核心技术,制备出OPL、OPO、LPL含量可控的功能性结构脂质,其中OPL、OPO和LPL的总含量可达到81.3-88.2wt%以上。同时,避免了现有技术中酸解反应制备OPL、OPO、LPL中的酰基迁移,副产物多,产率低的问题,并将所制备功能脂质和大豆油做对比添加至小鼠的饲料中进行短期喂养,监测小鼠的体重变化和肝脏甘油三酯和总胆固醇指标,为结构脂质的膳食应用提供理论依据。In order to solve the above problems, the present invention provides a method for preparing 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride and its application in mouse lipid metabolism. Through efficient and specific lipase and immobilization technology (from Thermomyces lanuginosus, Merck), using the core technology of spatial structure regulation and proportion regulation of structural lipids, functional structural lipids with controllable content of OPL, OPO and LPL are prepared, wherein the total content of OPL, OPO and LPL can reach more than 81.3-88.2wt%. At the same time, the problems of acyl migration, many by-products and low yield in the acid hydrolysis reaction in the prior art for preparing OPL, OPO and LPL are avoided, and the prepared functional lipids and soybean oil are compared and added to the feed of mice for short-term feeding, and the weight changes of mice and the liver triglyceride and total cholesterol indicators are monitored, providing a theoretical basis for the dietary application of structural lipids.
为解决上述技术问题,本发明采用的技术方案为:In order to solve the above technical problems, the technical solution adopted by the present invention is:
一种1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯的制备方法及对小鼠脂质代谢的应用:以富含三棕榈酸甘油三酯(PPP)的精炼棕榈油为原料(来自北大荒九三粮油工业集团有限公司),经水解特异性固定化脂肪酶催化,反应前半程只加入有机油酸,后半程加入有机亚油酸,待反应结束后经分子蒸馏去除游离脂肪酸,以最终获得富含OPO、OPL和LPL的有机油脂组合物,并将上述功能脂质喂养小鼠探究其对小鼠体重和血清生化指标,具体步骤如下。A preparation method of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride and its application to lipid metabolism in mice: using refined palm oil rich in tripalmitoyl triglyceride (PPP) as raw material (from Beidahuang Jiusan Grain and Oil Industry Group Co., Ltd.), catalyzed by hydrolysis-specific immobilized lipase, only organic oleic acid is added in the first half of the reaction, and organic linoleic acid is added in the second half, and after the reaction is completed, free fatty acids are removed by molecular distillation to finally obtain an organic oil composition rich in OPO, OPL and LPL, and the above-mentioned functional lipids are fed to mice to explore their effects on mouse body weight and serum biochemical indicators. The specific steps are as follows.
1)以富含三棕榈酸甘油三酯(PPP)的精炼棕榈油为原料,将一定量的原料放入到反应釜中,按照一定的转速搅拌预热。1) Using refined palm oil rich in tripalmitin (PPP) as raw material, a certain amount of the raw material is put into a reactor and stirred and preheated at a certain speed.
2)在无溶剂体系中,按照一定比例加入油酸至反应釜中搅拌均匀。2) In a solvent-free system, oleic acid is added into a reaction kettle according to a certain ratio and stirred evenly.
3)按照一定比例加入固定化脂肪酶Lipozyme TL IM,维持一定的反应温度和磁力搅拌转速。3) Add immobilized lipase Lipozyme TL IM in a certain proportion, and maintain a certain reaction temperature and magnetic stirring speed.
4)待反应进行一半时间时,加入一定比例的亚油酸和固定化脂肪酶Lipozyme TLIM,继续反应。4) When the reaction is halfway done, add a certain proportion of linoleic acid and immobilized lipase Lipozyme TLIM and continue the reaction.
5)反应结束后,离心去除固定化脂肪酶,并采用分子蒸馏去除游离脂肪酸,最终获得富含OPO、OPL和LPL的有机油脂组合物。5) After the reaction is completed, the immobilized lipase is removed by centrifugation, and free fatty acids are removed by molecular distillation, so as to finally obtain an organic oil composition rich in OPO, OPL and LPL.
6)运用高效液相色谱-质谱联用法测定最终反应产物中甘油三酯种类和含量。6) Use HPLC-MS/MS to determine the type and content of triglycerides in the final reaction product.
7)小鼠生长饲料购买于(北京科奥协力饲料有限公司),其主要成分为玉米,豆粕,鱼粉,面粉,酵母粉,食盐,多种维生素和矿物元素等。大豆油(来自北大荒九三粮油工业集团有限公司),20只6周龄健康小鼠(SPF级雌性BALB/c小鼠(18±2g),购自北京维通利华实验动物技术有限公司),实验环境温度20~25℃,湿度50%~54%,实验动物自由摄食饮水。每天给小鼠灌胃1次,每次灌胃剂量90μL/10g(有机油脂组合物体积/小鼠体重)。实验中,将小鼠分为4组(不同OPL、OPO和LPL含量的功能脂质组和大豆油组),每组5只。在饲养期间每天测量1次体重,饲养7天以便观察变化。将所制功能脂质和大豆油分别灌胃小鼠,监测小鼠的体重变化和肝脏甘油三酯和总胆固醇指标。7) Mouse growth feed was purchased from (Beijing Keao Xieli Feed Co., Ltd.), and its main ingredients are corn, soybean meal, fish meal, flour, yeast powder, salt, multiple vitamins and mineral elements, etc. Soybean oil (from Beidahuang Jiusan Grain and Oil Industry Group Co., Ltd.), 20 6-week-old healthy mice (SPF female BALB/c mice (18±2g), purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.), the experimental environment temperature is 20-25°C, the humidity is 50%-54%, and the experimental animals are free to eat and drink. The mice were gavaged once a day, and the gavage dose was 90μL/10g (volume of organic oil composition/mouse body weight) each time. In the experiment, the mice were divided into 4 groups (functional lipid groups with different OPL, OPO and LPL contents and soybean oil groups), with 5 mice in each group. The body weight was measured once a day during the feeding period, and the feeding was carried out for 7 days to observe the changes. The functional lipids and soybean oil prepared were gavaged into mice respectively, and the weight changes and liver triglyceride and total cholesterol indicators of the mice were monitored.
具体地,一种1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯的制备方法,包括如下步骤:Specifically, a method for preparing 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride comprises the following steps:
1)以富含三棕榈酸甘油三酯PPP的精炼棕榈油为原料,将原料放入到反应釜中,搅拌预热,预热温度为40-80℃;1) Using refined palm oil rich in tripalmitin triglyceride PPP as raw material, the raw material is placed in a reactor, stirred and preheated, and the preheating temperature is 40-80° C.;
2)在无溶剂体系中,加入油酸至反应釜中搅拌均匀,反应时间为2h-3h,反应温度为40-80℃;2) In a solvent-free system, add oleic acid to a reaction kettle and stir evenly. The reaction time is 2h-3h and the reaction temperature is 40-80°C;
3)加入一半的固定化脂肪酶Lipozyme TL IM,维持反应温度和磁力搅拌转速;3) Add half of the immobilized lipase Lipozyme TL IM and maintain the reaction temperature and magnetic stirring speed;
4)再加入亚油酸和剩余的固定化脂肪酶Lipozyme TL IM,继续反应;反应时间为2h-3h,反应温度为40-80℃;4) Add linoleic acid and the remaining immobilized lipase Lipozyme TL IM and continue the reaction; the reaction time is 2h-3h and the reaction temperature is 40-80°C;
5)反应结束后,离心去除固定化脂肪酶,并采用分子蒸馏去除游离脂肪酸,最终获得富含OPO、OPL和LPL的有机油脂组合物。5) After the reaction is completed, the immobilized lipase is removed by centrifugation, and free fatty acids are removed by molecular distillation, so as to finally obtain an organic oil composition rich in OPO, OPL and LPL.
优选的,三棕榈酸甘油酯含量80wt%~95wt%。Preferably, the content of tripalmitin is 80 wt% to 95 wt%.
优选的,反应温度为40-80℃。Preferably, the reaction temperature is 40-80°C.
优选的,精炼棕榈油与脂肪酸(油酸和亚油酸二者总量)的摩尔比为1:6-1:12。Preferably, the molar ratio of refined palm oil to fatty acids (the total amount of oleic acid and linoleic acid) is 1:6-1:12.
优选的,油酸和亚油酸的摩尔比为1:1-1:5。Preferably, the molar ratio of oleic acid to linoleic acid is 1:1-1:5.
优选的,所述固定化脂肪酶为Lipozyme TL IM,Lipozyme TL IM的添加总量为反应底物浓度的6%-14%,反应时间为4h-6h。Preferably, the immobilized lipase is Lipozyme TL IM, the total amount of Lipozyme TL IM added is 6%-14% of the concentration of the reaction substrate, and the reaction time is 4h-6h.
优选的,分子蒸馏绝对压力小于10Pa,温度为180℃-220℃,刮板转速为100-300r/min。Preferably, the absolute pressure of molecular distillation is less than 10 Pa, the temperature is 180° C.-220° C., and the scraper speed is 100-300 r/min.
优选的,磁力搅拌转速为500~800r/min。Preferably, the magnetic stirring speed is 500-800 r/min.
上述最终产物中OPL、OPO和LPL的总含量可达到82.4-88.2wt%,Sn-2棕榈酸含量85.8-90.7wt%。The total content of OPL, OPO and LPL in the final product can reach 82.4-88.2wt%, and the content of Sn-2 palmitic acid is 85.8-90.7wt%.
优选的,大豆油组小鼠平均体重18.3g增长到20.4g,肝脏甘油三酯(0.17mmol/g蛋白)和总胆固醇(0.07mmol/g蛋白),功能脂质组小鼠平均体重从18.2g减少到17.5g,肝脏甘油三酯(0.13-0.15mmol/g蛋白)和总胆固醇(0.04-0.05mmol/g蛋白)。Preferably, the average body weight of mice in the soybean oil group increased from 18.3g to 20.4g, liver triglycerides (0.17mmol/g protein) and total cholesterol (0.07mmol/g protein), and the average body weight of mice in the functional lipid group decreased from 18.2g to 17.5g, liver triglycerides (0.13-0.15mmol/g protein) and total cholesterol (0.04-0.05mmol/g protein).
1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备功能脂质中的应用。Application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride in the preparation of functional lipids.
功能脂质可有效控制体重增加,降低肝脏甘油三酯和总胆固醇水平。Functional lipids can effectively control weight gain and reduce liver triglyceride and total cholesterol levels.
1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备婴儿配方奶粉中的应用。Application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride in the preparation of infant formula milk powder.
与现有技术相比,本发明的有益效果是:Compared with the prior art, the present invention has the following beneficial effects:
1.本发明提供的一种1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯的制备方法,具有反应条件温和,选择性强,反应活性高,反应速度快,产品纯度高,品质好等优点,最终产物中OPL、OPO和LPL的总含量可达到82.4-88.2wt%,Sn-2棕榈酸含量85.8-90.7wt%,解决了传统方法中高温引起的酰基迁移,副产物多,产率低导致的母乳替代脂纯度较低等问题。1. The present invention provides a method for preparing 1,3-diunsaturated fatty acid-2-palmitic acid triglyceride, which has the advantages of mild reaction conditions, strong selectivity, high reaction activity, fast reaction speed, high product purity, good quality, etc. The total content of OPL, OPO and LPL in the final product can reach 82.4-88.2wt%, and the content of Sn-2 palmitic acid is 85.8-90.7wt%, which solves the problems of acyl migration caused by high temperature in traditional methods, many by-products, low purity of breast milk substitute fat caused by low yield, etc.
2.本发明通过控制油酸/亚油酸的添加比例和温度、时间等反应参数,调控油酸和亚油酸两种脂肪酸在甘油骨架上的酯化活性差异,可准确控制产物中OPL、OPO和LPL的比例,为满足不同组成的母乳脂替代物的开发提供了可靠方法。2. The present invention controls the addition ratio of oleic acid/linoleic acid and reaction parameters such as temperature and time to regulate the difference in esterification activity of oleic acid and linoleic acid on the glycerol backbone, thereby accurately controlling the ratio of OPL, OPO and LPL in the product, providing a reliable method for the development of breast milk fat substitutes with different compositions.
3.本发明通过产物分离纯化和脂肪酸回收,可实现脂肪酸的循环利用,绿色高效,无废弃物产生。3. The present invention can realize the recycling of fatty acids through product separation and purification and fatty acid recovery, which is green and efficient without generating waste.
4.固定化脂肪酶Lipozyme TL IM可循环重复使用,重复5次后,其酶的相对活力仍达到80%以上,有效提高了酶的利用率,降低了生产成本。4. Immobilized lipase Lipozyme TL IM can be reused cyclically. After 5 times, the relative activity of the enzyme still reaches more than 80%, which effectively improves the utilization rate of the enzyme and reduces the production cost.
5.所制备功能脂质,可以有效控制小鼠的体重增加,降低肝脏甘油三酯和总胆固醇水平,为功能脂质的膳食应用提供理论依据。5. The prepared functional lipids can effectively control the weight gain of mice, reduce the levels of liver triglycerides and total cholesterol, and provide a theoretical basis for the dietary application of functional lipids.
具体实施方式Detailed ways
实施例1Example 1
以三棕榈酸甘油三酯(PPP)含量为80wt%的精炼棕榈油为原料,将原料放入到反应釜中,搅拌预热,预热至50℃,经水解特异性固定化脂肪酶催化,反应前半程只加入有机油酸至反应釜中搅拌均匀,反应前半程的反应时间为2h,反应温度为50℃,前半程反应完成后获得反应底物,再向反应底物中加入固定化脂肪酶Lipozyme TL IM,Lipozyme TL IM的添加量为反应底物浓度的4%,维持50℃的反应温度和磁力搅拌转速(500r/min),进行后半程反应,后半程加入有机亚油酸,反应温度为50℃,反应后半程的反应时间为2h,精炼棕榈油与脂肪酸(油酸和亚油酸)的摩尔比为1:8,油酸和亚油酸的摩尔比为1:2,固定化脂肪酶Lipozyme TL IM的添加总量为反应底物浓度的8%,待反应结束后经分子蒸馏去除游离脂肪酸,分子蒸馏绝对压力小于10Pa,温度为180℃,刮板转速为100r/min。最终获得富含OPO、OPL和LPL的有机油脂组合物,其中OPL、OPO和LPL的总含量可达到82.4wt%,Sn-2棕榈酸含量85.8%。Refined palm oil with a tripalmitoyl triglyceride (PPP) content of 80wt% was used as a raw material. The raw material was placed in a reactor, stirred and preheated to 50°C, and catalyzed by hydrolysis-specific immobilized lipase. In the first half of the reaction, only organic oleic acid was added to the reactor and stirred evenly. The reaction time of the first half of the reaction was 2h, and the reaction temperature was 50°C. After the first half of the reaction was completed, a reaction substrate was obtained, and then immobilized lipase Lipozyme TL IM was added to the reaction substrate. The addition amount of Lipozyme TL IM was 4% of the concentration of the reaction substrate. The reaction temperature of 50°C and the magnetic stirring speed (500r/min) were maintained for the second half of the reaction. Organic linoleic acid was added in the second half, the reaction temperature was 50°C, the reaction time of the second half of the reaction was 2h, the molar ratio of refined palm oil to fatty acids (oleic acid and linoleic acid) was 1:8, the molar ratio of oleic acid to linoleic acid was 1:2, and the immobilized lipase Lipozyme TL The total amount of IM added is 8% of the reaction substrate concentration. After the reaction is completed, free fatty acids are removed by molecular distillation. The absolute pressure of molecular distillation is less than 10Pa, the temperature is 180°C, and the scraper speed is 100r/min. Finally, an organic oil composition rich in OPO, OPL and LPL is obtained, wherein the total content of OPL, OPO and LPL can reach 82.4wt%, and the content of Sn-2 palmitic acid is 85.8%.
小鼠生长饲料购买于(北京科奥协力饲料有限公司),其主要成分为玉米,豆粕,鱼粉,面粉,酵母粉,食盐,多种维生素和矿物元素等。大豆油(来自北大荒九三粮油工业集团有限公司),20只6周龄健康小鼠(SPF级雌性BALB/c小鼠(18±2g),购自北京维通利华实验动物技术有限公司),实验环境温度20~25℃,湿度50%~54%,实验动物自由摄食饮水。每天给小鼠灌胃1次,每次灌胃剂量90μL/10g(有机油脂组合物体积/小鼠体重)。实验中,将小鼠分为4组(不同OPL、OPO和LPL含量的功能脂质组和大豆油组),每组5只。在饲养期间每天测量1次体重,饲养7天,结果显示大豆油组小鼠平均体重18.3g增长到20.4g,肝脏甘油三酯(0.17mmol/g蛋白)和总胆固醇(0.07mmol/g蛋白),功能脂质组小鼠平均体重从18.2g减少到17.9g,肝脏甘油三酯(0.15mmol/g蛋白)和总胆固醇(0.05mmol/g蛋白)。Mouse growth feed was purchased from (Beijing Keao Xieli Feed Co., Ltd.), and its main ingredients are corn, soybean meal, fish meal, flour, yeast powder, salt, multiple vitamins and mineral elements, etc. Soybean oil (from Beidahuang Jiusan Grain and Oil Industry Group Co., Ltd.), 20 6-week-old healthy mice (SPF female BALB/c mice (18±2g), purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.), experimental environment temperature 20-25°C, humidity 50%-54%, experimental animals free access to food and water. Mice were gavaged once a day, each gavage dose was 90μL/10g (organic oil composition volume/mouse body weight). In the experiment, the mice were divided into 4 groups (functional lipid groups with different OPL, OPO and LPL contents and soybean oil groups), 5 mice in each group. The body weight was measured once a day during the feeding period for 7 days. The results showed that the average body weight of mice in the soybean oil group increased from 18.3g to 20.4g, liver triglycerides (0.17mmol/g protein) and total cholesterol (0.07mmol/g protein), while the average body weight of mice in the functional lipid group decreased from 18.2g to 17.9g, liver triglycerides (0.15mmol/g protein) and total cholesterol (0.05mmol/g protein).
本实施例获得的1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备功能脂质中的应用。The application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride obtained in this example in the preparation of functional lipids.
本实施例获得的1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备婴儿配方奶粉中的应用。Application of the 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride obtained in this example in the preparation of infant formula milk powder.
实施例2Example 2
以三棕榈酸甘油三酯(PPP)含量为95wt%的精炼棕榈油为原料,将原料放入到反应釜中,搅拌预热,预热至40℃,经水解特异性固定化脂肪酶催化,反应前半程只加入有机油酸至反应釜中搅拌均匀,反应前半程的反应时间为3h,反应温度为40℃,前半程反应完成后获得反应底物,再向反应底物中加入固定化脂肪酶Lipozyme TL IM,Lipozyme TL IM的添加量为反应底物浓度的5%,维持40℃的反应温度和磁力搅拌转速(800r/min),进行后半程反应,后半程加入有机亚油酸,反应温度为40℃,反应后半程的反应时间为3h,精炼棕榈油与脂肪酸(油酸和亚油酸)的摩尔比为1:10,油酸和亚油酸的摩尔比为1:3,固定化脂肪酶Lipozyme TL IM的添加量为反应底物浓度的10%,总反应时间为6h,待反应结束后经分子蒸馏去除游离脂肪酸,分子蒸馏绝对压力小于10Pa,温度为200℃,刮板转速为200r/min。最终获得富含OPO、OPL和LPL的有机油脂组合物,其中OPL、OPO和LPL的总含量可达到88.2wt%,Sn-2棕榈酸含量90.7%。Refined palm oil with a tripalmitoyl triglyceride (PPP) content of 95wt% was used as a raw material. The raw material was placed in a reactor, stirred and preheated to 40°C, and catalyzed by hydrolysis-specific immobilized lipase. In the first half of the reaction, only organic oleic acid was added to the reactor and stirred evenly. The reaction time of the first half of the reaction was 3h and the reaction temperature was 40°C. After the first half of the reaction was completed, a reaction substrate was obtained, and then immobilized lipase Lipozyme TL IM was added to the reaction substrate. The addition amount of Lipozyme TL IM was 5% of the concentration of the reaction substrate. The reaction temperature of 40°C and the magnetic stirring speed (800r/min) were maintained for the second half of the reaction. Organic linoleic acid was added in the second half, the reaction temperature was 40°C, the reaction time of the second half of the reaction was 3h, the molar ratio of refined palm oil to fatty acids (oleic acid and linoleic acid) was 1:10, the molar ratio of oleic acid to linoleic acid was 1:3, and the immobilized lipase Lipozyme TL The addition amount of IM is 10% of the reaction substrate concentration, the total reaction time is 6 hours, and after the reaction is completed, free fatty acids are removed by molecular distillation, the absolute pressure of molecular distillation is less than 10Pa, the temperature is 200°C, and the scraper speed is 200r/min. Finally, an organic oil composition rich in OPO, OPL and LPL is obtained, wherein the total content of OPL, OPO and LPL can reach 88.2wt%, and the content of Sn-2 palmitic acid is 90.7%.
将实施例2所制备功能脂质配合饲料喂养小鼠,其他步骤与实施例1相同。结果显示功能脂质组小鼠平均体重从18.2g减少到17.5g,肝脏甘油三酯(0.13mmol/g蛋白)和总胆固醇(0.04mmol/g蛋白)。The functional lipid feed prepared in Example 2 was fed to mice, and the other steps were the same as in Example 1. The results showed that the average body weight of mice in the functional lipid group decreased from 18.2 g to 17.5 g, liver triglyceride (0.13 mmol/g protein) and total cholesterol (0.04 mmol/g protein).
本实施例获得的1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备功能脂质中的应用。The application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride obtained in this example in the preparation of functional lipids.
本实施例获得的1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备婴儿配方奶粉中的应用。Application of the 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride obtained in this example in the preparation of infant formula milk powder.
实施例3Example 3
以三棕榈酸甘油三酯(PPP)含量为90wt%的精炼棕榈油为原料,将原料放入到反应釜中,搅拌预热,预热至70℃,经水解特异性固定化脂肪酶催化,反应前半程只加入有机油酸至反应釜中搅拌均匀,反应前半程的反应时间为3h,反应温度为70℃,前半程反应完成后获得反应底物,再向反应底物中加入固定化脂肪酶Lipozyme TL IM,Lipozyme TL IM的添加量为反应底物浓度的6%,维持70℃的反应温度和磁力搅拌转速(600r/min),进行后半程反应,后半程加入有机亚油酸,反应温度为70℃,精炼棕榈油与脂肪酸(油酸和亚油酸)的摩尔比为1:12,油酸和亚油酸的摩尔比为1:4,固定化脂肪酶Lipozyme TL IM的添加量为反应底物浓度的12%,反应时间为6h,待反应结束后经分子蒸馏去除游离脂肪酸,分子蒸馏绝对压力小于10Pa,温度为220℃,刮板转速为300r/min。最终获得富含OPO、OPL和LPL的有机油脂组合物,其中OPL、OPO和LPL的总含量可达到85.6wt%,Sn-2棕榈酸含量87.5%。Refined palm oil with a tripalmitoyl triglyceride (PPP) content of 90wt% was used as a raw material. The raw material was placed in a reactor, stirred and preheated to 70°C, and catalyzed by hydrolysis-specific immobilized lipase. In the first half of the reaction, only organic oleic acid was added to the reactor and stirred evenly. The reaction time of the first half of the reaction was 3h and the reaction temperature was 70°C. After the first half of the reaction was completed, a reaction substrate was obtained, and then immobilized lipase Lipozyme TL IM was added to the reaction substrate. The addition amount of Lipozyme TL IM was 6% of the concentration of the reaction substrate. The reaction temperature of 70°C and the magnetic stirring speed (600r/min) were maintained for the second half of the reaction. Organic linoleic acid was added in the second half, and the reaction temperature was 70°C. The molar ratio of refined palm oil to fatty acids (oleic acid and linoleic acid) was 1:12, the molar ratio of oleic acid to linoleic acid was 1:4, and the immobilized lipase Lipozyme TL The addition amount of IM is 12% of the reaction substrate concentration, the reaction time is 6 hours, and after the reaction is completed, free fatty acids are removed by molecular distillation, the absolute pressure of molecular distillation is less than 10Pa, the temperature is 220°C, and the scraper speed is 300r/min. Finally, an organic oil composition rich in OPO, OPL and LPL is obtained, wherein the total content of OPL, OPO and LPL can reach 85.6wt%, and the content of Sn-2 palmitic acid is 87.5%.
将实施例3所制备功能脂质配合饲料喂养小鼠,其他步骤与实施例1相同。结果显示功能脂质组小鼠平均体重从18.2g减少到17.7g,肝脏甘油三酯(0.14mmol/g蛋白)和总胆固醇(0.045mmol/g蛋白)。The functional lipid feed prepared in Example 3 was fed to mice, and the other steps were the same as in Example 1. The results showed that the average body weight of mice in the functional lipid group decreased from 18.2 g to 17.7 g, liver triglyceride (0.14 mmol/g protein) and total cholesterol (0.045 mmol/g protein).
本实施例获得的1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备功能脂质中的应用。The application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride obtained in this example in the preparation of functional lipids.
本实施例获得的1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备婴儿配方奶粉中的应用。Application of the 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride obtained in this example in the preparation of infant formula milk powder.
实施例4Example 4
本实施例与实施例1的区别仅在于:The difference between this embodiment and embodiment 1 is only that:
以三棕榈酸甘油三酯(PPP)含量为92wt%的精炼棕榈油为原料,将原料放入到反应釜中,搅拌预热,预热至80℃,经水解特异性固定化脂肪酶催化,反应前半程只加入有机油酸至反应釜中搅拌均匀,反应前半程的反应时间为2h,反应温度为80℃,前半程反应完成后获得反应底物,再向反应底物中加入固定化脂肪酶Lipozyme TL IM,Lipozyme TL IM的添加量为反应底物浓度的3%,维持80℃的反应温度和磁力搅拌转速(700r/min),进行后半程反应,后半程加入有机亚油酸,反应温度为80℃,精炼棕榈油与脂肪酸(油酸和亚油酸)的摩尔比为1:6,油酸和亚油酸的摩尔比为1:1,固定化脂肪酶Lipozyme TL IM的总添加量为反应底物浓度的6%,反应总时间为4h,待反应结束后经分子蒸馏去除游离脂肪酸,分子蒸馏绝对压力小于10Pa,温度为190℃,刮板转速为150r/min。最终获得富含OPO、OPL和LPL的有机油脂组合物,其中OPL、OPO和LPL的总含量可达到83.1wt%,Sn-2棕榈酸含量85.7%。Refined palm oil with a tripalmitoyl triglyceride (PPP) content of 92wt% was used as a raw material. The raw material was placed in a reactor, stirred and preheated to 80°C, and catalyzed by hydrolysis-specific immobilized lipase. In the first half of the reaction, only organic oleic acid was added to the reactor and stirred evenly. The reaction time of the first half of the reaction was 2h and the reaction temperature was 80°C. After the first half of the reaction was completed, a reaction substrate was obtained, and then immobilized lipase Lipozyme TL IM was added to the reaction substrate. The addition amount of Lipozyme TL IM was 3% of the reaction substrate concentration. The reaction temperature of 80°C and the magnetic stirring speed (700r/min) were maintained for the second half of the reaction. Organic linoleic acid was added in the second half, and the reaction temperature was 80°C. The molar ratio of refined palm oil to fatty acids (oleic acid and linoleic acid) was 1:6, the molar ratio of oleic acid to linoleic acid was 1:1, and the immobilized lipase Lipozyme TL The total amount of IM added is 6% of the reaction substrate concentration, the total reaction time is 4 hours, and after the reaction is completed, free fatty acids are removed by molecular distillation, the absolute pressure of molecular distillation is less than 10Pa, the temperature is 190°C, and the scraper speed is 150r/min. Finally, an organic oil composition rich in OPO, OPL and LPL is obtained, wherein the total content of OPL, OPO and LPL can reach 83.1wt%, and the content of Sn-2 palmitic acid is 85.7%.
本实施例获得的1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备功能脂质中的应用。The application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride obtained in this example in the preparation of functional lipids.
本实施例获得的1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备婴儿配方奶粉中的应用。Application of the 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride obtained in this example in the preparation of infant formula milk powder.
实施例5Example 5
本实施例与实施例1的区别仅在于:The difference between this embodiment and embodiment 1 is only that:
以三棕榈酸甘油三酯(PPP)含量为88wt%的精炼棕榈油为原料,将原料放入到反应釜中,搅拌预热,预热至55℃,经水解特异性固定化脂肪酶催化,反应前半程只加入有机油酸至反应釜中搅拌均匀,反应前半程的反应时间为2.5h,反应温度为55℃,前半程反应完成后获得反应底物,再向反应底物中加入固定化脂肪酶Lipozyme TL IM,Lipozyme TL IM的添加量为反应底物浓度的7%,维持55℃的反应温度和磁力搅拌转速(550r/min),进行后半程反应,后半程加入有机亚油酸,反应温度为55℃,精炼棕榈油与脂肪酸(油酸和亚油酸)的摩尔比为1:7,油酸和亚油酸的摩尔比为1:5,固定化脂肪酶Lipozyme TL IM的总添加量为反应底物浓度的14%,反应总时间为5h,待反应结束后经分子蒸馏去除游离脂肪酸,分子蒸馏绝对压力小于10Pa,温度为210℃,刮板转速为180r/min。最终获得富含OPO、OPL和LPL的有机油脂组合物,其中OPL、OPO和LPL的总含量可达到87.4wt%,Sn-2棕榈酸含量88.9%。Refined palm oil with a tripalmitoyl triglyceride (PPP) content of 88wt% was used as a raw material. The raw material was placed in a reactor, stirred and preheated to 55°C, and catalyzed by hydrolysis-specific immobilized lipase. In the first half of the reaction, only organic oleic acid was added to the reactor and stirred evenly. The reaction time of the first half of the reaction was 2.5h, and the reaction temperature was 55°C. After the first half of the reaction was completed, a reaction substrate was obtained, and then immobilized lipase Lipozyme TL IM was added to the reaction substrate. The addition amount of Lipozyme TL IM was 7% of the concentration of the reaction substrate. The reaction temperature of 55°C and the magnetic stirring speed (550r/min) were maintained for the second half of the reaction. Organic linoleic acid was added in the second half, and the reaction temperature was 55°C. The molar ratio of refined palm oil to fatty acids (oleic acid and linoleic acid) was 1:7, the molar ratio of oleic acid to linoleic acid was 1:5, and the immobilized lipase Lipozyme TL The total amount of IM added is 14% of the reaction substrate concentration, the total reaction time is 5 hours, and after the reaction is completed, free fatty acids are removed by molecular distillation, the absolute pressure of molecular distillation is less than 10Pa, the temperature is 210°C, and the scraper speed is 180r/min. Finally, an organic oil composition rich in OPO, OPL and LPL is obtained, wherein the total content of OPL, OPO and LPL can reach 87.4wt%, and the content of Sn-2 palmitic acid is 88.9%.
本实施例获得的1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备功能脂质中的应用。The application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride obtained in this example in the preparation of functional lipids.
本实施例获得的1,3-二不饱和脂肪酸-2-棕榈酸甘油三酯在制备婴儿配方奶粉中的应用。Application of the 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride obtained in this example in the preparation of infant formula milk powder.
虽然本发明已以较佳实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人,在不脱离本发明的精神和范围内,都可做各种的改动与修饰,因此本发明的保护范围应该以权利要求书所界定的为准。Although the present invention has been disclosed as above in the preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410345594.3A CN118166045A (en) | 2024-03-26 | 2024-03-26 | Preparation method and application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410345594.3A CN118166045A (en) | 2024-03-26 | 2024-03-26 | Preparation method and application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118166045A true CN118166045A (en) | 2024-06-11 |
Family
ID=91358329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410345594.3A Pending CN118166045A (en) | 2024-03-26 | 2024-03-26 | Preparation method and application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118166045A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN120102767A (en) * | 2025-05-09 | 2025-06-06 | 赞宇科技集团股份有限公司 | A synthetic OPO lipase enzyme activity detection reagent and detection method thereof |
-
2024
- 2024-03-26 CN CN202410345594.3A patent/CN118166045A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN120102767A (en) * | 2025-05-09 | 2025-06-06 | 赞宇科技集团股份有限公司 | A synthetic OPO lipase enzyme activity detection reagent and detection method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102827885B (en) | Composition and method of making the same containing 1,3-bis-unsaturated fatty acyl-2-saturated fatty acyl glyceryl ester and purposes | |
CN104855542B (en) | The human milk of a kind of combination enzyme process acidolysis and physical mixed substitutes the preparation method of fat | |
US11525150B2 (en) | Methods for producing polyunsaturated fatty acid and lipid containing polyunsaturated fatty acid | |
CN102845537B (en) | Preparation method of human milk fat substitute | |
TWI439546B (en) | Production of polyunsaturated fatty acids using novel cell treatment method | |
TWI352122B (en) | A crude oil, a refined oil, and a general food and | |
US20080175975A1 (en) | Method For Producing a Dha-Containing Fatty Acid Composition | |
CN100588713C (en) | Process for the production of transesterified oils/fats or triglycerides | |
CN104862350A (en) | Method for preparing 1, 3-dilinolein-2-palmitic acid triglyceride | |
CN101037641A (en) | Process for producing fat comprising triglyceride containing highly unsaturated fatty acid | |
CN100362107C (en) | Production method of diglyceride edible oil | |
CN118166045A (en) | Preparation method and application of 1,3-diunsaturated fatty acid-2-palmitoyl triglyceride | |
CN107549332A (en) | Strengthen method of baby's long-chain polyunsaturated fatty acid bioavailability and products thereof | |
CN111172210A (en) | Method for preparing arachidonic acid glyceride rich by two-step enzyme method and product thereof | |
CN111996218B (en) | A kind of method for preparing diglyceride by enzymatic method | |
CA2524880C (en) | Manufacture of conjugated linoleic salts and acids | |
JP3120906B2 (en) | Method for producing triglyceride containing β-palmitic acid | |
US7078051B1 (en) | Conjugated linoleic acid alkyl esters in feedstuffs and food | |
CN107974471B (en) | Method for synthesizing triglyceride with medium-long chain structure by mixed catalysis | |
CN106822081A (en) | A kind of phosphatide type punicic acid fat or oil composition and its preparation method and application | |
CN113832200B (en) | Preparation method of breast milk structured fat | |
CN103710400B (en) | The method of tg cla is rich in a kind of sn-2 of preparation position | |
CN117223799A (en) | Broiler feed capable of improving feed conversion ratio of broiler and preparation method of broiler feed | |
US11396667B2 (en) | Enzymatic method for preparation of lecithin polyunsaturated fatty acids (PUFAs) | |
CN112956596B (en) | A preparation method of duck fat fatty acid glyceride for feed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |